| Handling missing data in within-trial cost-effectiveness analysis: a review with future recommendations A Gabrio, AJ Mason, G Baio PharmacoEconomics-open 1 (2), 79-97, 2017 | 18 | 2017 |
| A full Bayesian model to handle structural ones and missingness in economic evaluations from individual‐level data A Gabrio, AJ Mason, G Baio Statistics in medicine 38 (8), 1399-1420, 2019 | 10 | 2019 |
| A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations A Gabrio, MJ Daniels, G Baio Journal of the Royal Statistical Society: Series A (Statistics in Society …, 2020 | 3 | 2020 |
| Bayesian hierarchical models for the prediction of volleyball results A Gabrio Journal of Applied Statistics 48 (2), 301-321, 2021 | 1 | 2021 |
| Bayesian Statistical Economic Evaluation Methods for Health Technology Assessment A Gabrio, G Baio, A Manca Oxford Research Encyclopedia of Economics and Finance, 2019 | 1 | 2019 |
| Joint Longitudinal Models for Dealing With Missing at Random Data in Trial-Based Economic Evaluations A Gabrio, R Hunter, AJ Mason, G Baio Value in Health, 2021 | | 2021 |
| A Bayesian framework for patient-level partitioned survival cost-utility analysis A Gabrio arXiv preprint arXiv:2011.10732, 2020 | | 2020 |
| Full Bayesian Methods to Handle Missing Data in Health Economic Evaluation A Gabrio UCL (University College London), 2019 | | 2019 |
| Pitfalls of adjusting for mean baseline utilities/costs in trial-based cost-effectiveness analysis with missing data A Gabrio, R Hunter, AJ Mason, G Baio arXiv preprint arXiv:1805.07149, 2018 | | 2018 |
| Augmented Inverse Probability Weighting A Gabrio, M Data | | |
